Bionano

San Diego, United States Founded: 2002 • Age: 24 yrs
Provider of genome analysis solutions to researchers and clinicians
Request Access

About Bionano

Bionano is a company based in San Diego (United States) founded in 2002.. Bionano has raised $124.2 million across 27 funding rounds from investors including NIH, HHS and National Cancer Institute. The company has 100 employees as of December 31, 2024. Bionano has completed 1 acquisition, including BioDiscovery. Bionano operates in a competitive market with competitors including Nanopore, PacBio, Omniome, Complete Genomics and QuantuMDx, among others.

  • Headquarter San Diego, United States
  • Employees 100 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
    Technology
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Bionano Genomics, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Technology → Quantum & Emerging Technologies
Key Metrics
  • Annual Revenue
    $30.78 M
    -14.79
    as on Dec 31, 2024
  • Net Profit
    $-112.02 M
    51.82
    as on Dec 31, 2024
  • EBITDA
    $-71.48 M
    43.14
    as on Dec 31, 2024
  • Total Equity Funding
    $124.2 M (USD)

    in 27 rounds

  • Latest Funding Round
    $20 M (USD), Post-IPO

    May 24, 2024

  • Investors
    NIH

    & 15 more

  • Employee Count
    100

    as on Dec 31, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Bionano

Bionano is a publicly listed company on the NASDAQ with ticker symbol BNGO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: BNGO . Sector: Health technology · USA
People of Bionano
Headcount 200-500
Employee Profiles 32
Employee Profiles
People
Melissa Bjork
Associate Director, Logistics And Distribution At Bionano
People
Spencer Baker
Associate Director, Supply Chain
People
Taylor Daly King
Talent Acquisition Consultant
People
Erik Holmlin
President & CEO

Unlock access to complete

Funding Insights of Bionano

Bionano has successfully raised a total of $124.2M across 27 strategic funding rounds. The most recent funding activity was a Post-IPO round of $20 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 27
  • Last Round Post-IPO — $20.0M
  • First Round
  • Investors Count 16
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2024 Amount Post-IPO - Bionano Valuation

investors

Mar, 2019 Amount Post-IPO - Bionano Valuation

investors

Dec, 2014 Amount Series C - Bionano Valuation Legend Capital , Novartis Venture Fund
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Bionano

Bionano has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and National Cancer Institute. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture Capital firm focused on multiple sectors
Founded Year Domain Location
Investments are made in innovative life science companies globally.
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Bionano

Bionano has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include BioDiscovery. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Software solutions for microarray and next-generation sequencing analysis are provided.
1997
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Bionano

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Bionano Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Bionano

Bionano operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Omniome, Complete Genomics and QuantuMDx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Nanopore-based electronic systems for single-molecule analysis are developed.
domain founded_year HQ Location
Instrument systems and software for single-molecule real-time sequencing are developed.
domain founded_year HQ Location
Genome sequencing platform is provided for clinical diagnostics.
domain founded_year HQ Location
DNA sequencing platform for human genome analysis is developed.
domain founded_year HQ Location
Handheld diagnostic and sequencing devices are developed for personalized healthcare.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Bionano

Frequently Asked Questions about Bionano

When was Bionano founded?

Bionano was founded in 2002 and raised its 1st funding round 3 years after it was founded.

Where is Bionano located?

Bionano is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Who is the current CEO of Bionano?

Erik Holmlin is the current CEO of Bionano.

Is Bionano a funded company?

Bionano is a funded company, having raised a total of $124.2M across 27 funding rounds to date. The company's 1st funding round was a Series C of $68.44M, raised on Jun 01, 2005.

How many employees does Bionano have?

As of Dec 31, 2024, the latest employee count at Bionano is 100.

What is the annual revenue of Bionano?

Annual revenue of Bionano is $30.78M as on Dec 31, 2024.

What does Bionano do?

Founded in 2002 and based in San Diego, United States, Bionano operates in the biotechnology sector, focusing on genome analysis tools. The Saphyr system is utilized for non-sequencing optical mapping of long genomic DNA strands. This technology is applied to identify structural variants overlooked by next-generation sequencing and traditional cytogenetic methods, supporting research and clinical applications.

Who are the top competitors of Bionano?

Bionano's top competitors include Nanopore, PacBio and QuantuMDx.

Is Bionano publicly traded?

Yes, Bionano is publicly traded on NASDAQ under the ticker symbol BNGO.

How many acquisitions has Bionano made?

Bionano has made 1 acquisition, including BioDiscovery.

Who are Bionano's investors?

Bionano has 16 investors. Key investors include NIH, HHS, National Cancer Institute, Ben Franklin Technology Partners, and NHGRI.

What is Bionano's ticker symbol?

The ticker symbol of Bionano is BNGO on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available